Atomico has led $56m series B round for Cambridge-allied rare disease therapy developer Healx, which also welcomed Intel Capital as a new shareholder.

Sequis Life led a series C round for online healthcare and insurance portal Alodokter that included Philips and existing investor SoftBank Ventures Asia.

Lilly Asia Ventures returned for the respiratory disease drug developer's series B round, having co-led its $85m series A last year.

University of Michigan has generated 86 spinouts over the past five years after setting a new record of 22 during its most recent financial year.

Ahren Innovation Capital has led a $16m initial series A tranche for Mogrify, co-founded by researchers from Bristol, Monash and Duke universities.

The Chernin Group-backed personalised care provider plans to use the series B funding to expand into new cities and take its telemedicine offering nationwide.

Humana provided $20m for healthcare assistance platform Accolade through the widening of a strategic agreement signed in March.

In mid-October there were six Global Corporate Venturing stories on life sciences startups raising capital.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

The fund will provide capital for MIT-founded Gingko's own spinouts and has attracted LPs including Viking Global Investors, General Atlantic and Cascade Investment.